Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

ose excursion following an oral glucose load or a meal. In studies with healthy subjects, JANUVIA did not lower blood glucose or cause hypoglycemia. Cardiac Electrophysiology In a randomized, placebo-controlled crossover study, 79 healthy subjects were administered a single oral dose of JANUVIA 100 mg, JANUVIA 800 mg (8 times the recommended dose), and placebo. At the recommended dose of 100 mg, there was no effect on the QTc interval obtained at the peak plasma concentration, or at any other time during the study. Following the 800 mg dose, the maximum increase in the placebo-corrected mean change in QTc from baseline was observed at 3 hours postdose and was 8.0 msec. This increase is not considered to be clinically significant. At the 800 mg dose, peak sitagliptin plasma concentrations were approximately 11-fold higher than the peak concentrations following a 100 mg dose. In patients with type 2 diabetes administered JANUVIA 100 mg (N=81) or JANUVIA 200 mg (N=63) daily, there were no meaningful changes in QTc interval based on ECG data obtained at the time of expected peak plasma concentration. 12.3 Pharmacokinetics The pharmacokinetics of sitagliptin has been extensively characterized in healthy subjects and patients with type 2 diabetes. After oral administration of a 100 mg dose to healthy subjects, sitagliptin was rapidly absorbed, with peak plasma concentrations (median Tmax) occurring 1 to 4 hours postdose. Plasma AUC of sitagliptin increased in a dose-proportional manner. Following a single oral 100 mg dose to healthy volunteers, mean plasma AUC of sitagliptin was 8.52 ?M-hr, Cmax was 950 nM, and apparent terminal half-life (t1/2) was 12.4 hours. Plasma AUC of sitagliptin increased approximately 14% following 100 mg doses at steady-state compared to the first dose. The intra-subject and inter-subject coefficients of variation for sitagliptin AUC were small (5.8% and 15.1%). The pharmacokinetics o
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
(Date:7/2/2015)... , July 2, 2015 According to ... Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), ... Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation ... projected to reach $6.20 Billion by 2020, at a CAGR ... 8 4 market data T ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
(Date:7/3/2015)... ... 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... will reveal biblical truth and expose popular lies regarding proper relationships according to the ... Sex”, immediately goes into the core of the subject by explaining why certain types ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech Report, ... technology expert and special reporter for NewsWatch, conducted the review and shared with viewers ... , According to the U.S. Department of Energy, it’s very important to use energy-efficient ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... for embryonic development can quickly become a potent cancer promoter ... from Fox Chase Cancer Center, causing white blood cells to ... the journal Cancer Research, the researchers detail how a gene ... drive cancer in mice. The protein that Dlx5 encodes could ...
... leave nation vulnerable to disease, bioterror and health, threats according to ... ... Public Health, WASHINGTON, Feb. 27 While natural disasters,the threat ... resources, the U.S. is facing a major public health,workforce crisis that could ...
... 27 Riverview Medical,Center, located in Red ... under the J.D. Power and Associates Distinguished ... by Riverview,Medical Center to provide an "outstanding ... ), The service excellence distinction was ...
... Vaccination Programs Using FluMist(R) May Serve as Model ... Help Vaccinate Large Numbers of Eligible ... MedImmune, the manufacturer,of FluMist(R) (Influenza Virus Vaccine Live, ... and Prevention,s (CDC) Advisory Committee,on Immunization Practices (ACIP) ...
... to health care might help to overcome racial and ethnic ... the March 2008 issue of Clinical Journal of the American ... "yet another wake-up call as to how we as a ... nation, including the reduction and/or elimination of health disparities," according ...
... KAN. -- Despite millions of dollars spent on food safety ... to E. coli O157:H7 were higher in 2007 than in ... Texas A&M University. E. coli O157:H7 has been linked to ... , "We have been studying the effects of a novel ...
Cached Medicine News:Health News:Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 3Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 2Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 4Health News:Race, insurance status affect access to transplantation and kidney disease treatment 2Health News:Race, insurance status affect access to transplantation and kidney disease treatment 3Health News:Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle 2
Lorgnette pinhole occluder...
Long handle occluder - Black...
Long handle occluder - White...
6 inch hand held occlcuder with 49 holes...
Medicine Products: